Functional Movement Disorder Comorbidity in Parkinson’s Disease: a Multicenter Descriptive Study in Spain
Objective: To describe clinical and demographic characteristics of a Spanish cohort with Parkinson's Disease (PD) and Functional Movement Disorder (FMD) comorbidity. Background: Functional overlay in…Patient-specific multivariate gray matter volumetric distance to predict disease severity in Parkinson’s disease
Objective: Identifying novel biomarkers to predict disease progression is of paramount importance in patients with Parkinson’s disease (PD). In this study, we utilized Structural Magnetic…Outcomes of surgical management of pelvic floor dysfunction in women with Parkinson’s disease
Objective: To assess the effect of Parkinson’s disease (PD) on outcomes of surgical management in women with pelvic floor dysfunction (PFD). Background: PFD is more…Long-term wearable tele-rehabilitation of gait for persons with Parkinson’s disease: A feasibility study
Objective: This study aims to evaluate the feasibility of long-term wearable tele-rehabilitation of gait in people with Parkinson’s disease. Background: Tele-rehabilitation allows patients to utilize…Caregiving patients with Parkinson disease treated with deep brain stimulation: a systematic review and meta-synthesis of qualitative research
Objective: To explore the experiences and unmet needs of Parkinson disease patients (PDPs) caregivers after subthalamic nucleus deep brain stimulation (STN-DBS) by performing a systematic…Evoked resonant neural activity within the dorsolateral subthalamic nucleus as a biomarker for the targeting of deep brain stimulation for Parkinson’s disease
Objective: The objective of the study was to determine the anatomical localisation of evoked resonant neural activity (ERNA), which is being investigated as a potential…Apomorphine sublingual film patient-reported motor status response at home throughout the day
Objective: To assess the efficacy throughout the day of self-administered apomorphine sublingual film (SL-APO) compared with placebo (PLC) for the treatment of OFF episodes in…Time-to-event approach mitigates the treatment masking effect of symptomatics on MDS-UPDRS Part III
Objective: To assess whether a time-to-event (TTE) approach may mitigate the masking effect of changing symptomatic therapy on Movement Disorders Society–Unified Parkinson’s Disease (PD) Rating…Awake versus Asleep Deep Brain Stimulation Lead Placement: Real-World Outcomes with Directional DBS Systems
Objective: In this report, real-world outcomes derived from Parkinson's disease (PD) patients using Deep Brain Stimulation (DBS) Systems who were implanted either awake or asleep…Pattern of non-motor symptoms in Parkinson’s disease: A prospective observational study
Objective: Assessment of non-motor symptoms of PD in a cohort of patients attending a tertiary care hospital Background: Nonmotor symptoms are highly prevalent in PD…
- « Previous Page
- 1
- …
- 246
- 247
- 248
- 249
- 250
- …
- 338
- Next Page »